Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Stem Cell Reports. 2015 Oct 13;5(4):471-9. doi: 10.1016/j.stemcr.2015.08.010. Epub 2015 Sep 10.
Hematopoietic stem and progenitor cells (HSPCs) are born from hemogenic endothelium in the dorsal aorta. Specification of this hematopoietic niche is regulated by a signaling axis using Hedgehog (Hh) and Notch, which culminates in expression of Runx1 in the ventral wall of the artery. Here, we demonstrate that the vitamin D precursor cholecalciferol (D3) modulates HSPC production by impairing hemogenic vascular niche formation. Accumulation of D3 through exogenous treatment or inhibition of Cyp2r1, the enzyme required for D3 25-hydroxylation, results in Hh pathway antagonism marked by loss of Gli-reporter activation, defects in vascular niche identity, and reduced HSPCs. Mechanistic studies indicated the effect was specific to D3, and not active 1,25-dihydroxy vitamin D3, acting on the extracellular sterol-binding domain of Smoothened. These findings highlight a direct impact of inefficient vitamin D synthesis on cell fate commitment and maturation in Hh-regulated tissues, which may have implications beyond hemogenic endothelium specification.
造血干细胞和祖细胞 (HSPCs) 起源于背主动脉中的血发生内皮细胞。这个造血龛位的特化受到 Hedgehog(Hh)和 Notch 信号轴的调节,最终导致动脉腹侧壁上 Runx1 的表达。在这里,我们证明了维生素 D 前体胆钙化醇(D3)通过损害血发生血管龛位形成来调节 HSPC 的产生。通过外源性处理或抑制 Cyp2r1(D3 25-羟化所需的酶)积累 D3,会导致 Hh 通路拮抗,表现为 Gli 报告基因激活丧失、血管龛位特征缺陷和 HSPC 减少。机制研究表明,这种作用是 D3 的特异性作用,而不是活性 1,25-二羟维生素 D3,作用于 Smoothened 的细胞外固醇结合域。这些发现强调了低效维生素 D 合成对 Hh 调节组织中细胞命运决定和成熟的直接影响,这可能超出了血发生内皮细胞特化的范围。